ADAPALENE AND BENZOYL PEROXIDE
Clinical safety rating: avoid
Adapalene and benzoyl peroxide is a fixed-dose topical combination indicated for the treatment of acne vulgaris. Adapalene is a retinoid that modulates follicular keratinization and inflammation, while benzoyl peroxide is an oxidizing agent with bactericidal and keratolytic properties, offering complementary mechanisms to reduce inflammatory and non-inflammatory lesions.
Adapalene is a retinoid that binds to retinoic acid receptors (RAR-β and RAR-γ) and modulates gene expression, reducing follicular hyperkeratinization and comedogenesis. Benzoyl peroxide is an oxidizing agent with bactericidal activity against Propionibacterium acnes and mild keratolytic effect.
| Metabolism | Adapalene: primarily metabolized via O-demethylation and hydroxylation by cytochrome P450 isoenzymes (CYP2C8, CYP3A4). Benzoyl peroxide: degraded to benzoic acid in the skin and then conjugated with glycine to form hippuric acid, which is excreted renally. |
| Excretion | Primarily fecal (roughly 70%) via biliary elimination; renal excretion is minimal (<10%). |
| Half-life | Adapalene: 7–10 hours (topical); benzoyl peroxide: rapidly degraded to benzoic acid (half-life ~1 hour). |
| Protein binding | Adapalene: >95% bound to plasma proteins (primarily albumin); benzoyl peroxide: not systemically absorbed. |
| Volume of Distribution | Not applicable for topical application; negligible systemic absorption. |
| Bioavailability | Topical: negligible systemic absorption (<5% of applied dose). |
| Onset of Action | Topical: within 2–4 weeks for reduction of acne lesions. |
| Duration of Action | Topical: effects persist with continued use; no data for single-dose duration. |
| Molecular Weight | 240.3 |
Apply a thin layer to the entire affected area (e.g., face, chest, back) once daily in the evening after gentle cleansing. For adapalene 0.1%/benzoyl peroxide 2.5% gel: pea-sized amount for the face; increase dose gradually based on tolerability. For adapalene 0.3%/benzoyl peroxide 2.5% gel: same regimen, approved for moderate to severe acne. Do not apply to eyes, lips, or mucous membranes. Use a non-comedogenic moisturizer as needed to mitigate irritation.
| Dosage form | GEL |
| Renal impairment | No dosage adjustment is required. Systemic absorption is negligible; formal studies in renal impairment have not been conducted. |
| Liver impairment | No dosage adjustment is required. Systemic exposure is minimal and unlikely to be affected by hepatic impairment. Not studied in hepatic dysfunction. |
| Pediatric use | Adapalene 0.1%/benzoyl peroxide 2.5% gel: safety and efficacy established in pediatric patients aged 9 years and older; use same dosing as adults. Adapalene 0.3%/benzoyl peroxide 2.5% gel: safety and efficacy established in pediatric patients aged 12 years and older. Not recommended for children under 9 years (0.1%) or under 12 years (0.3%) due to lack of data. |
| Geriatric use | Clinical studies did not include sufficient numbers of subjects aged 65 and over to determine differential response. No specific dose adjustment is recommended; use with caution and monitor for increased skin irritation. |
| 1st trimester | Topical use is generally not recommended due to limited safety data; avoid if possible. |
| 2nd trimester | Limited data; use only if potential benefit justifies risk. |
| 3rd trimester | Avoid near term due to theoretical risk of premature closure of ductus arteriosus with benzoyl peroxide systemic absorption. |
Clinical note
Use during pregnancy only if the potential benefit justifies the potential risk to the fetus. There are no adequate and well-controlled studies in pregnant women. Adapalene has been associated with teratogenicity in animal studies at supraphysiologic oral doses, but systemic exposure after topical use is minimal. Benzoyl peroxide is generally considered low risk. Nevertheless, it should be used with caution or avoided during pregnancy, particularly during the first trimester.
| FDA category | Contraindicated |
| Placental transfer | Unlikely significant due to low systemic absorption after topical application; no data on transfer. |
■ FDA Black Box Warning
None
| Common Effects | Dry skin, Erythema, Scaling/peeling, Pruritus, Mild burning/stinging sensation at application site |
| Serious Effects | Severe hypersensitivity reactions (angioedema, anaphylaxis), Severe persistent skin irritation or chemical burns, Allergic contact dermatitis (topical benzoyl peroxide) |
Hypersensitivity to adapalene, benzoyl peroxide, or any component of the formulation
| Precautions | For external use only; avoid contact with eyes, lips, mouth, and mucous membranes., May cause erythema, scaling, dryness, or stinging; use sun protection and avoid excessive sun exposure., Avoid use on broken or eczematous skin., May cause photosensitivity; minimize exposure to UV light., Use with caution in patients with eczema or sensitive skin. |
| Food/Dietary |
Loading safety data…
| Breastfeeding | Minimal systemic absorption after topical application; unlikely to cause adverse effects in breastfed infant. Use with caution on small areas. |
| Lactation Rating | L2 (Probably Compatible) |
| Teratogenic Risk | Topical adapalene and benzoyl peroxide have minimal systemic absorption; no fetal risks identified in animal studies for benzoyl peroxide; adapalene is teratogenic in rats and rabbits at oral doses 0.3-2.0 mg/kg/day but not at topical doses. First trimester: insufficient human data; second and third trimester: no known risk with topical use. Overall, risk is low with topical application. |
| Fetal Monitoring | No specific monitoring required for topical use. Standard prenatal care; assess for local skin reactions. |
| Fertility Effects | No known effect on fertility based on limited data. |
| No significant food interactions. |
| Clinical Pearls | Combination product for acne vulgaris; apply thin layer once daily; avoid concurrent use with other topical retinoids or benzoyl peroxide products to prevent excessive irritation; use sunscreen and avoid excessive sun exposure; may bleach hair and fabrics; onset of action may take 2-4 weeks. |
| Patient Advice | Apply a pea-sized amount to clean, dry skin once daily in the evening. · Avoid contact with eyes, mouth, and mucous membranes. · May cause redness, peeling, and dryness; use moisturizer if needed. · Use sunscreen daily and avoid prolonged sun exposure. · Do not use other acne products unless directed by your doctor. · May bleach colored fabrics and hair; avoid contact. · Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding. |